EXAS

#511
Exact Sciences Corp
103.3800
+0.16%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
103.3800
103.3800
Годовой диапазон
62.3900
103.6700
Дневное изменение
+0.16%
Месячное изменение
+1.04%
6-месячное изменение
+59.44%
Годовое изменение
+59.44%
Предыдущее закрытие
103.2100
Open
103.3800
Bid
Ask
Low
103.3800
High
103.3800
Объем
93
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
  • Market Capitalization 19.5066 B
  • Employee 7 200
  • Founded 1995
  • CEO Kevin Conroy
  • Website www.exactsciences.com
  • Headquarter Wisconsin, United States
  • FIGI BBG000CWL0F5
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-92.33
Price to sales ratio
5.9
Dividends per share
—
Dividend yield %
—

Exact Sciences Corporation

Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer. In November 2025, Abbott Laboratories agreed to acquire Exact Sciences in a deal worth roughly $21 billion.

Новости